Efficacy and safety of ustekinumab as maintenance therapy in ulcerative colitis: Week 44 results from UNIFI

被引：0
|
作者：
Sandborn, W. J. [1 ]
Sands, B. E. [2 ]
Panaccione, R. [3 ]
O'Brien, C. D. [4 ]
Zhang, H. [4 ]
Johanns, J. [4 ]
Peyrin-Biroulet, L. [5 ]
Van Assche, G. [6 ]
Danese, S. [7 ]
Targan, S. R. [8 ]
Abreu, M. T. [9 ]
Hisamatsu, T. [10 ]
Szapary, P. [4 ]
Marano, C. [4 ]
机构：
[1] Univ Calif San Diego, La Jolla, CA 92093 USA
[2] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[3] Univ Calgary, Calgary, AB, Canada
[4] Janssen Res & Dev LLC, Spring House, PA USA
[5] Univ Lorraine, Nancy Univ Hosp, Nancy, France
[6] Univ Leuven, Leuven, Belgium
[7] Humanitas Res Hosp, Milan, Italy
[8] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[9] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[10] Kyorin Univ, Tokyo, Japan
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP37
引用
收藏
页码：S26 / S26
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of vedolizumab in the maintenance phase of ulcerative colitis
    Torralba, K. S.
    Payawal, D. A.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 267 - 268
  • [42] SUSTAINED REMISSION IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 3 UNIFI MAINTENANCE STUDY
    Van Assche, Gert A.
    Targan, Stephan R.
    Baker, Thomas
    O'Brien, Christopher D.
    Zhang, Hongyan
    Johanns, Jewel
    Szapary, Philippe
    Marano, Colleen W.
    Leong, Rupert W.
    Rowbotham, David
    Hisamatsu, Tadakazu
    Danese, Silvio
    Sands, Bruce E.
    Peyrin-Biroulet, Laurent
    GASTROENTEROLOGY, 2019, 156 (06) : S1106 - S1107
  • [43] Sustained remission in patients with moderate to severe ulcerative colitis: Results from the Phase 3 UNIFI maintenance study
    Van Assche, G.
    Targan, S. R.
    Baker, T.
    O'Brien, C. D.
    Zhang, H.
    Johanns, J.
    Szapary, P.
    Marano, C.
    Leong, R. W.
    Rowbotham, D.
    Hisamatsu, T.
    Danese, S.
    Sands, B. E.
    Peyrin-Biroulet, L.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S54 - S55
  • [44] Sustained remission in patients with moderate to severe ulcerative colitis: Results from the Phase III UNIFI maintenance study
    Van Assche, G.
    Targan, S.
    Baker, T.
    O'Brien, C.
    Zhang, H.
    Johanns, J.
    Szapary, P.
    Marano, C.
    Leong, R.
    Rowbotham, D.
    Hisamatsu, T.
    Danese, S.
    Sands, B.
    Peyrin-Biroulet, L.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 154 - 155
  • [45] Efficacy and safety of intravenous ustekinumab re-induction therapy in Crohn's disease patients with secondary loss of response to ustekinumab maintenance therapy: Week 16 results from the POWER trial
    Schreiber, S. W.
    Lee, S.
    Van der Woude, C. J.
    Marin-Jimenez, I.
    Wolf, D.
    Schnoy, E.
    Salzberg, B.
    Busse, C.
    Nazar, M.
    Langholff, W.
    Borghorst, S.
    Gasink, C.
    Baker, T.
    Godwin, B.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 564 - 564
  • [46] CLINICAL AND MOLECULAR CHARACTERIZATION OF PATIENTS WITH DURABLE RESPONSE TO USTEKINUMAB INDUCTION THERAPY: RESULTS FROM THE UNIFI PHASE 3 STUDIES IN MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Li, Katherine
    Yang, Feifei
    Hayden, Karen
    Strawn, David
    Wadman, Eric
    Bhagat, Sunita
    Marano, Colleen W.
    Friedman, Joshua
    GASTROENTEROLOGY, 2020, 158 (06) : S1191 - S1191
  • [47] EFFICACY AND SAFETY OF INTRAVENOUS USTEKINUMAB RE-INDUCTION THERAPY IN CROHN'S DISEASE PATIENTS WITH SECONDARY LOSS OF RESPONSE TO USTEKINUMAB MAINTENANCE THERAPY: WEEK 16 RESULTS FROM THE POWER TRIAL
    Lee, Scott D.
    Schreiber, Stefan
    Janneke, Christien
    Van der Woude
    Marin-Jimenez, Ignacio
    Wolf, Douglas C.
    Schnoy, Elisabeth
    Salzberg, Bruce
    Busse, Christopher
    Nazar, Maciej
    Langholff, Wayne
    Borghorst, Stephan
    Gasink, Christopher
    Baker, Thomas
    Godwin, Bridget
    Feagan, Brian G.
    GASTROENTEROLOGY, 2023, 164 (06) : S220 - S220
  • [48] Efficacy of ustekinumab for Ulcerative Colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
    Danese, S.
    Afif, W.
    Abreu, M.
    Sandborn, W.
    Miao, Y.
    Zhang, H.
    Panaccione, R.
    Hisamatsu, T.
    Scherl, E.
    Leong, R.
    Rowbotham, D.
    Arasaradnam, R.
    Peyrin-Biroulet, L.
    Sands, B.
    Marano, C.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I19 - I20
  • [49] Clinical and molecular characterisation of patients with durable response to ustekinumab induction therapy: Results from the UNIFI phase 3 studies in moderate-to-severe ulcerative colitis
    Li, K.
    Yang, F.
    Hayden, K.
    Strawn, D.
    Wadman, E.
    Bhagat, S.
    Marano, C.
    Friednman, J. R.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S070 - S071
  • [50] Efficacy of ustekinumab for ulcerative colitis through 4 years: Final clinical and endoscopy outcomes from the UNIFI long-term extension
    Danese, S.
    Afif, W.
    Abreu, M. T.
    Sandborn, W. J.
    Miao, Y.
    Zhang, H.
    Panaccione, R.
    Hisamatsu, T.
    Scherl, E. J.
    Leong, R.
    Rowbotham, D. S.
    Arasaradnam, R. P.
    Peyrin-Biroulet, L.
    Sands, B. E.
    Marano, C.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 117 - 118
12345